Amanta Healthcare Limited (NSE:AMANTA)

Amanta Healthcare Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	148.75	105.01	36.33	-21.11	538.82
Depreciation & Amortization	187.3	182.75	196.6	182.77	172.09
Other Amortization	-	1.24	0.7	0.7	0.7
Loss (Gain) From Sale of Assets	0.5	1	0.25	4.64	-
Loss (Gain) From Sale of Investments	-4.48	-5.01	-2.48	-1.33	-1.31
Provision & Write-off of Bad Debts	10.48	13.17	8.39	14.49	9.12
Other Operating Activities	205.94	278.55	291.2	318.94	-171.39
Change in Accounts Receivable	67.11	-13.08	47.25	-96.46	55.2
Change in Inventory	-97.33	-135.29	94.74	21.78	-138.58
Change in Accounts Payable	52.35	55.12	-112.75	-35.74	144.36
Change in Unearned Revenue	26.67	-22.15	29.62	14.42	6.45
Change in Other Net Operating Assets	-112.83	4.9	-9.11	22.71	19.89
Operating Cash Flow	484.46	466.2	580.73	425.8	635.34
Operating Cash Flow Growth	3.92%	-19.72%	36.38%	-32.98%	90.26%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-801.86	-207.74	-134.11	-62.91	-99.72
Sale of Property, Plant & Equipment	1.53	1.86	14.27	0.06	71.6
Investment in Securities	-143.18	-41.93	13.02	-4.67	-29.25
Other Investing Activities	7.42	3.09	3.61	2.2	3.56
Investing Cash Flow	-936.09	-244.73	-103.21	-65.32	-53.81

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	10.88	-	70.38	-	34.19
Long-Term Debt Issued	786.19	1,280	263.99	128.53	1,651
Total Debt Issued	797.07	1,280	334.36	128.53	1,685
Short-Term Debt Repaid	-	-21.64	-	-65.74	-
Long-Term Debt Repaid	-315.59	-1,400	-525.01	-190.8	-1,792
Total Debt Repaid	-315.59	-1,421	-525.01	-256.53	-1,792
Net Debt Issued (Repaid)	481.47	-141.43	-190.64	-128	-106.95
Issuance of Common Stock	1,260	200	-	-	-
Preferred Dividends Paid	-4.05	-10	-10.02	-5.04	-
Dividends Paid	-4.05	-10	-10.02	-5.04	-
Other Financing Activities	-364.53	-283.23	-262.57	-290.17	-412.92
Financing Cash Flow	1,260	-234.66	-463.24	-423.21	-519.87

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	807.9	-13.19	14.28	-62.72	61.66

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	-317.4	258.46	446.62	362.9	535.62
Free Cash Flow Growth	-	-42.13%	23.07%	-32.25%	169.05%
Free Cash Flow Margin	-11.03%	9.41%	15.93%	14.00%	23.76%
Free Cash Flow Per Share	-9.24	9.14	16.65	13.53	19.96
Levered Free Cash Flow	-440.15	-83.4	135.23	-26.02	191.65
Unlevered Free Cash Flow	-310.49	85.13	337.72	188.88	460.76

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	187.63	203.62	250.17	281.32	404.37
Cash Income Tax Paid	70.57	38	59.46	63.11	0.97
Change in Working Capital	-64.03	-110.5	49.74	-73.3	87.32

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 25, 2026

Data Sources Report a data error